Article
Biological determinants of bleeding in patients with heterozygous factor XI deficiency.
British journal of haematology - 1 Jan 2012
Guéguen Paul, Galinat Hubert, Blouch Marie-Thérèse, Bridey Françoise, Duchemin Jérôme, Le Gal Grégoire, Abgrall Jean-François, Pan-Petesch Brigitte
Abstract excerpt
Bleeding risk is not predictable in patients with factor XI (FXI; F11) deficiency. In this prospective study, our objectives were to determine the biological determinants for bleeding risk in patients with heterozygous FXI deficiency. Patients were classified as either bleeding patients or non-bleeding patients by calculating the bleeding score (BS) described for von Willebrand disease. Primary haemostasis,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
